Xing Yi, Guo Jin-Yu, Liu Peng, Guo Quan-Lei, Cheng Xiu-Mei, Kang Jia-Meng, Ren Yan-Qing
Hebei University of Chinese Medicine Shijiazhuang 050091, China Hebei Traditional Chinese Medicine Formula Granule Technology Innovation Center Shijiazhuang 050091, China Quality Evaluation & Standardization Hebei Province Engineering Research Center of Traditional Chinese Medicine Shijiazhuang 050091, China.
Hebei University of Chinese Medicine Shijiazhuang 050091, China.
Zhongguo Zhong Yao Za Zhi. 2024 Jul;49(14):3818-3827. doi: 10.19540/j.cnki.cjcmm.20240207.401.
To explore the mechanism of Liangfang Wenjing Decoction regulating coiled-coil-helix coiled-coil-helix domain containing 4(CHCHD4) in the treatment of hypoxia on endometriosis(EMs) with cold coagulation and blood stasis. The rat model of cold coagulation and blood stasis syndrome was prepared by the ice-water bath method, and then the EMs model was established by autologous intimal transplantation. The rats were randomly divided into model group, low, medium, and high(4.7, 9.4, and 18.8 g·kg~(-1)) dose groups of Liangfang Wenjing Decoction, Shaofu Zhuyu Decoction group, and sham group, with 10 rats in each group. The rats were given intragastric administration for four weeks. During the modeling, the general condition and vaginal smear of rats were observed, and the blood flow of ears and uterus were detected by laser speckle contrast imaging(LSCI) to judge the syndrome of cold coagulation and blood stasis. After the administration, the general condition of the rats was observed, and the area of ectopic lesions was measured by caliper. The localization and expression of CHCHD4 and hypoxia inducible factors-1α(HIF-1α) were detected by immunohistochemistry, and the mRNA and protein expressions of CHCHD4 and HIF-1α were detected by real-time quantitative polymerase chain reaction(RT-qPCR) and Western blot. The primary culture of ectopic endometrial stromal cells(ESCs) from EMs patients was performed, and the CHCHD4 overexpression plasmid was constructed and transfected to establish the ESCs model of CHCHD4 overexpression. The cells were divided into the control group, CHCHD4 overexpression group, CHCHD4 overexpression+control serum group, and CHCHD4 overexpression+Liangfang Wenjing Decoction serum group. The protein expression of CHCHD4 and HIF-1α was detected by Western blot, and the glucose consumption and lactic acid level were detected. The cell proliferation was detected by MTT assay. The experiment found that compared with normal rats, the modeling rats showed symptoms of cold coagulation and blood stasis, such as mental malaise, reduced diet and drinking water, disordered estrous cycle, and blocked blood circulation in ears and uterine microvessels. Compared with the sham group, the ectopic lesions in the model group were uplifted, and the mRNA and protein expressions of CHCHD4 and HIF-1α were significantly increased(P<0.05). Compared with the model group, the symptoms of cold coagulation and blood stasis in each treatment group were improved, and the area of ectopic lesions was significantly reduced(P<0.05 or P<0.01). The mRNA and protein expression levels of CHCHD4 and HIF-1α were significantly decreased(P<0.05 or P<0.01). In the cell model, compared with the control group, the expression of CHCHD4, HIF-1α protein, glucose consumption, lactic acid level, and cell proliferation activity in the CHCHD4 overexpression group were significantly increased(P<0.01). Compared with the CHCHD4 overexpression group, there was no significant change in each index in the control serum group, while the protein expression of CHCHD4 and HIF-1α in the Liangfang Wenjing Decoction serum group was decreased significantly(P<0.05 or P<0.01). The glucose consumption, lactic acid level, and cell proliferation activity decreased significantly(P<0.01). It can be seen from the above that the therapeutic effect of Liangfang Wenjing Decoction on EMs with cold coagulation and blood stasis might be related to reducing the expression of CHCHD4 and then improving the hypoxia of ectopic lesions and ectopic ESCs.
探讨良附温经汤治疗寒凝血瘀型子宫内膜异位症(EMs)时调控卷曲螺旋-螺旋-卷曲螺旋结构域蛋白4(CHCHD4)的作用机制。采用冰水浴法制备寒凝血瘀证大鼠模型,然后通过自体内膜移植建立EMs模型。将大鼠随机分为模型组、良附温经汤低、中、高(4.7、9.4、18.8 g·kg⁻¹)剂量组、少腹逐瘀汤组和假手术组,每组10只。大鼠连续灌胃四周。造模期间,观察大鼠的一般情况及阴道涂片,并通过激光散斑对比成像(LSCI)检测耳部和子宫的血流,以判断寒凝血瘀证。给药后,观察大鼠的一般情况,并用游标卡尺测量异位病灶面积。采用免疫组织化学法检测CHCHD4和缺氧诱导因子-1α(HIF-1α)的定位及表达,采用实时定量聚合酶链反应(RT-qPCR)和蛋白质免疫印迹法(Western blot)检测CHCHD4和HIF-1α的mRNA及蛋白表达。对EMs患者的异位子宫内膜间质细胞(ESCs)进行原代培养,构建CHCHD4过表达质粒并转染,建立CHCHD4过表达的ESCs模型。将细胞分为对照组、CHCHD4过表达组、CHCHD4过表达+对照血清组和CHCHD4过表达+良附温经汤血清组。采用Western blot检测CHCHD4和HIF-1α的蛋白表达,检测葡萄糖消耗和乳酸水平。采用MTT法检测细胞增殖。实验发现,与正常大鼠相比,造模大鼠出现寒凝血瘀症状,如精神萎靡、饮食饮水减少、发情周期紊乱以及耳部和子宫微血管血液循环受阻。与假手术组相比,模型组的异位病灶隆起,CHCHD4和HIF-1α的mRNA及蛋白表达显著增加(P<0.05)。与模型组相比,各治疗组的寒凝血瘀症状均有改善,异位病灶面积显著减小(P<0.05或P<0.01)。CHCHD4和HIF-1α的mRNA及蛋白表达水平显著降低(P<0.05或P<0.01)。在细胞模型中,与对照组相比,CHCHD4过表达组中CHCHD4、HIF-1α蛋白表达、葡萄糖消耗、乳酸水平及细胞增殖活性均显著增加(P<0.01)。与CHCHD4过表达组相比,对照血清组各指标无明显变化,而良附温经汤血清组中CHCHD4和HIF-1α蛋白表达显著降低(P<0.05或P<0.01)。葡萄糖消耗、乳酸水平及细胞增殖活性显著降低(P<0.01)。由此可见,良附温经汤治疗寒凝血瘀型EMs的疗效可能与降低CHCHD4表达,进而改善异位病灶及异位ESCs的缺氧状态有关。